However, to explore the possibility that these peptides might modulate glucose homeostasis via their effects on circulating levels of glucagon, glucagon secretion from islets treated with GEP44 or GEP12 was measured, both in the presence and the absence of Y1-R antagonists (Fig
The PIONEER 6 cardiovascular outcomes trial demonstrated that oral semaglutide was non-inferior to placebo for major adverse cardiovascular events (MACE) in high-risk patients
IRS2 knockout mice exhibit hyperphagic obesity (108, 109) and this phenotype might be partly attributed to impaired insulin signaling in vagal afferent nerves (107)
Finally, the FLOW trial may shed further light on the potential mechanisms involved on how GLP-1 receptor agonism could alter renal physiology, combined with future mechanistic studies that aim to find proof for the effects of GLP-1 receptor agonists on the renal risk factors/pathophysiological mechanisms related to DKD as summarized in this review
Nat Gantz I et al (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
Glenn Lyle leads the surgical team, bringing advanced techniques and artistry to every procedure